DatasetName,CLUH_S(605) CLUH_S(649) CLUH_S(652) CLUH_S(664) CLUH_S(669),CLUH_S(1304) CLUH_S(596) CLUH_S(653) CLUH_S(702) CLUH_S(723)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.6211856643597768,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5709637690886714,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5921347095807532,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5952842585568453,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5903815766034717,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.6104174819401867,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.6045087098425753,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.6250265401711517,
WZ2023_Pu_010_30min,0.626524549838211,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.6135208955771886,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.5976343076357361,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5745172101034434,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.6127624851109598,
PG2020_Intensity 8h_C,0.5809934597897772,
AH2018_SILAC_MR_2_N,0.6162024756973963,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.6126100455959256,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.6080674845063111,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5911933658454094,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.6131554148213588,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.6008807712995221,
GF2025_P6_Sph,0.5703852309497689,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5953670090304827,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6235037214833457,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.6248589706128586,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5934244572976899,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6265648711889684,
AH2018_SILAC_MR_2_X,0.6139818799184334,
HS2024_4_PD_T2,0.6479587939482196,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.6327899039949144,
FR2021_Norm.Intensity.B,0.5766220992646575,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.6022509680129431,
RB2022_5_PostSprint,0.6091044290678416,
EJN2021_3_Rest_Basal,,0.4526746028636466
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5912850055406553,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5733909653969045,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.6319521575596768,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6271081934455903,
CK2022_11 40-1,0.5920796020440481,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5716446472600532,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.631648726043865,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.6258535727194183,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.621256780991003,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5886177620593284,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,0.5967447971274559,
AH2018_LFQ_M_1_C,0.617181164788579,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.6001315710444264,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,0.5919366310465818,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.6326880036643361,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5873640034615072,
CK2022_1 200-1,0.607167665019159,
PG2020_Intensity Mock_10h_D,0.588733339477556,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.617460570851067,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.5985043841662347,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5925563161122382,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.5969962251767131,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,0.6079600673716121,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.6276753967065127,
PG2020_Intensity 2h_C,0.5862747235794098,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5942412313215479,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.6022402492487291,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6174346527573904,
CK2022_3 40-1,0.5962891243965054,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5484001244853915,
YA2020_Reporter_intensity_Cancer_No.5,0.6200483920589053,
HH2022_Reporter intensity 8,,0.46385910593444163
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,0.449716892799407
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.5773497493344537,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5892608307138957,
YA2020_Reporter_intensity_Normal_No.1,0.6189272595000392,
HS2024_3_B_T1,0.6055265833799459,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.5985767501210596,
RB2022_1_PostEndurance,0.6034574161749404,
CR2017_Ratio Replicate 3,0.6206727032354052,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.5784049243752959,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5972013831506141,
HS2024_8_I_T3,,
CF2017_EOC 3,,0.442500763265234
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.6100881934746726,
HS2024_6_PD_T3,0.6035296123345484,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6229918599347004,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5959809348112263,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5682546408419287,
KS2014_Intensity N3,0.6204644016106602,0.47754819618362526
RB2022_4_RecoveryEndurance,0.6131139542389441,
RB2022_5_RecoveryEndurance,0.5987099655865901,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5939224407671999,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.4503200118777183
KS2014_Intensity E15_2,0.6273427297990783,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.579102308588037,
HS2024_7_I_T1,0.5737663651077953,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.6444611196755462,
AH2018_SILAC_M_3_X,0.5922430628455267,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5941030986906511,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6095595808615718,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.6180740791244633,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6258646316887763,
HS2024_6_B_N1,0.645142175597907,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.5860980767766651,
AH2018_SILAC_IT_3_X,0.5824545626716455,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5869857899415909,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.47406887317899704
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5862956838698923,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5870562387846254,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6097906312916408,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5859665124274887,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5847741841373228,
EJN2021_4_Rest_Ins,,0.45225261793158006
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.6100861266284274,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.609724737549554,
EJN2021_1_Rest_Ins,,0.4406854449122967
HH2022_Reporter intensity 3,,0.4147083914626618
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5906750670192578,
JW2021_After_3,,
GF2025_P8_Sph,0.5879959434948496,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5709863236051337,
CK2022_11 200-1,0.6099645081461758,
CK2022_12 200-1,0.6115918825970506,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.46001387962426943
WZ2023_Su_010_20min,0.6267183980885184,
AH2018_TMTMS2_2_N,0.5805081398514911,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.6222645416081474,0.4669597720932721
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.45311266769201036
CK2022_14 200-1,0.6051006744310169,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.6059994158226709,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5897429913150379,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.44724323415133577
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5746410768385599,
GF2025_P1_Adh,0.5942155532914087,
GF2025_P1_Sph,0.6008705044429744,
EJN2021_5_Ex_Basal,,0.4514215722993929
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6299743816254834,
CF2017_EOC 1,,0.4433685958926549
CK2022_3 200-1,0.6081597050522748,
AH2018_LFQ_IT_3_C,0.5708004205964382,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.613882065432207,
HS2024_5_B_T1,0.6020322061803433,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.6176107586341443,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5964317188071921,
RB2022_1_PostSprint,0.6095089858072784,
CK2022_4 200-1,0.6086833325291768,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5778868994575213,
AR2021_ALG 1 μM,0.5796578193663986,
HS2024_4_B_T1,0.5633212867576792,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.44564209921108355
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.6114559279237242,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.6076656553244574,
CK2022_9 16-1,0.5835988028270851,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.6049079958082273,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5680489786621001,
CK2022_16 16-1,0.5740918891893811,
FS2019_db/db3,,
CK2022_15 40-1,0.5859072798325446,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6285950858661018,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5716072863424255,
HS2024_5_PD_T3,0.6051924005163407,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,0.61856368194713,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.594776796711199,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5999979338502623,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.59924113047565,
YA2020_Reporter_intensity_Normal_No.4,0.616761763556982,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5768258492503636,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5736039088839413,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.6117294938653288,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.6665557487016801,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5917984498803017,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6122943859071421,
HH2022_Reporter intensity 6,,0.47069029573933074
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6334443365622278,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5827040079569834,
GF2025_P3_Adh,0.5996027685191048,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5770701158406044,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5602510482819506,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.6028344692771737,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.620198788786358,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.6074215638582083,
RB2022_7_RecoverySprint,0.6229036293465802,
YA2020_Reporter_intensity_Normal_No.3,0.6114048707512982,
HS2024_8_B_T2,0.5936519390575772,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,0.5760891686410898,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6215556830748332,0.4597974700005055
HH2022_Reporter intensity 1,,0.4169597335412649
HH2022_Reporter intensity 2,,0.41543677317504
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.6238299450134798,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.569613306953457,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.601825587092281,
CR2017_Ratio Replicate 2,0.5911386970538708,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5622714920035283,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.590034867718452,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5881986870448908,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.6463879361640128,
PG2020_Intensity 10h_A,0.5617749843203067,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5902035343977051,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,0.5870553099168974,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5861502569928332,
RB2022_7_RecoveryEndurance,0.5961659953325487,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.4497901142513914
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5739465541258784,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.6325271640966111,
RB2022_1_PreSprint,0.596259300937529,
HS2024_4_I_N1,0.6022658233385574,
CK2022_7 200-1,0.6018564330702716,
CK2022_5 200-1,0.602124979090764,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,0.6189327131988053,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5902301030794705,
EJN2021_5_Rest_Ins,,0.4508515095466808
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5933209964319469,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.4401290115349619
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5348933758503198,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.6489956951041319,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.5868155959337028,
AH2018_SILAC_IT_1_X,0.5822735663305739,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.6074271124851638,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5910339333689728,
WZ2023_Pe_025_20min,0.6234769281828875,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.5836967104862762,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.579062594664628,
AH2018_TMTMS2_3_N,0.5764963380707064,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.659964937786975,
WZ2023_Su_005_30min,0.6256677342341821,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.6075724143550726,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6248724031690218,
WZ2023_Su_025_10min,0.6231699382993747,
AH2018_LFQ_IT_4_X,0.5912728839983028,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6247995891435724,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.6067948489304518,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,0.5767343784516822,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.6026643801427174,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.4654106249544789
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5809074176101086,
LY2019_P7+,0.6081261814650141,
EP2017_Untreated R#1 normalized log2 ratio,0.5793987540095001,
RN2012_L10,,
PG2020_Intensity 4h_C,0.5728329252272555,
EP2017_Mitotic R#3 normalized log2 ratio,0.5931087007923584,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,0.6010384464328532,
AH2018_SILAC_IT_2_X,0.5828612887935306,
HS2024_4_B_T3,0.5928240285444473,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.629722385758059,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5553644244608157,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.5771539984614279,
CR2017_Ratio Replicate 1.1,0.6040599382677228,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.604533436474618,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5949393241049825,
GF2025_P9_Sph,0.5939248377001064,
CK2022_6 200-1,0.6026230756764545,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.6478575133562374,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.584492641704035,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5781441111845874,
EP2017_Untreated R#3 normalized log2 ratio,0.619989881585297,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.6014216398970664,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.610563516663903,
RB2022_7_PostEndurance,0.6268324359971784,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5756391832347364,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5707908507734888,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.6552799399307757,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.4444068864442451
FR2021_Intensity.M,0.5760891686410898,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.6185164733848134,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.4565891748200781
PG2020_Intensity CT_C,0.5813129726075077,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.6210484691108733,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.6146113457356648,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.5805274730396859,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.6196571786063245,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.598106914910171,
CR2017_Ratio Replicate 2.3,0.5845369804849352,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.6017813572615732,
YA2020_Reporter_intensity_Normal_No.2,0.6114026271909893,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.6339780945032304,
HS2024_3_PD_T3,0.6176458168831112,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.5835515153497667,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6190341577027394,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.5926122874342005,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.45228436213065554
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.6076971807134386,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5628772493310289,
PG2020_Intensity Mock_10h_B,0.588496365387597,
WZ2023_Su_025_30min,0.6225056481975815,
AH2018_LFQ_4_N,0.6136954016974009,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.6324560740315637,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.4781978012158713
AH2018_SILAC_M_1_X,0.5972742512681822,
RB2022_7_PreEndurance,0.5909204694559099,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5956133279320559,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5801892436932995,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.6136718786193635,
KS2014_Intensity C5,0.6314035157664791,0.4189535535733195
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.6099229450112478,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.6146080693564431,
RB2022_3_PostStrength,0.6172628287295927,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.6059066032381852,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.6182232220455676,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5718690845404517,
AH2018_LFQ_2_X,0.6115033908826971,
PG2020_Intensity 2h_B,0.5772389824254864,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.5998161532785863,
KS2014_Intensity E15_3,0.6329259492906699,
GF2025_P3_Sph,0.594110250693157,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5921552905614755,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5859888310172527,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.6125245209002452,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.583169928478162,
ZQ2022_N1,,
LY2019_P6-,0.5882498008032391,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.6074619230878979,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.6124266339520356,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.6073185140083182,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.5928515870020619,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5856726132701086,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5857734505158214,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.5927882404829421,
HS2024_5_PD_T2,0.599768090599016,
WZ2023_Su_025_20min,0.6242446410575171,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5990024694487789,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.6001622545027583,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5851663440515807,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.5811683957569082,
RB2022_8_PreEndurance,0.6033826123796323,
HS2024_3_B_N2,0.6223300618211141,
EJN2021_4_Ex_Ins,,0.45114282331083266
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.44916313598992536
EP2017_Pervanadate R#3 log2 ratio,0.5927118043459199,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.6157173748107144,
AH2018_LFQ_M_4_C,0.6145844165926226,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.586241178296395,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5641073441652853,
FR2021_Intensity.A,0.5838548824236021,
EJN2021_3_Ex_Ins,,0.43715799000828814
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6289216199164305,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.4366989412631278
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5696821784585617,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6274944534580535,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.6049966626846853,
GF2025_P10_Adh,0.5962496649228507,
RB2022_1_RecoveryStrength,0.5948948053597702,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,0.6025786766075379,
HS2024_5_B_N1,0.6189943223614882,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5785973726273688,
RB2022_4_PreSprint,0.5998081736952235,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5941757309557354,
RB2022_3_RecoveryStrength,0.6235061070629335,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5948512713621786,
LY2019_P8+,0.5844859498527499,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.6024535722457827,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6143242244319659,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,0.5643185468504015,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.6386671467754464,
AH2018_LFQ_IT_1_X,0.5966170247123677,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6281813246781741,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.5960307970971659,
HS2024_3_I_T1,0.5931056590508064,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,0.615176669919803,
CK2022_4 40-1,0.5976166095132666,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5949571167471494,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,0.602564872903272,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6177308339163385,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5932142554428569,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6249444335579284,
KS2014_Intensity C2,0.6300249643422287,0.43107864790361267
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.609715407160663,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.6095486165014485,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.6262857626968449,
RBK2021_1332T Late,,
LY2019_P1-,0.6182755790867432,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5887173753949517,
HS2024_3_I_T3,0.610524033795526,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.6189897321180341,0.41886979564794513
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.4529833596460537
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5799841993326588,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6293831069966477,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6243773373825938,0.4694656407017824
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.6084708784341033,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6046586774214341,
LATM2013_Log2 Ratio (Medium/Light) Forward,0.6099344683855998,
PG2020_Intensity 2h_A,0.5736485863160115,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.616877186082758,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5791110080222367,
HS2024_5_I_N1,0.5815412251897981,
HS2024_6_I_N1,0.6348915096665361,
AR2021_KD 48h,0.5752525500162056,
FR2021_Intensity.B,0.5765728409911782,
RB2022_3_PreEndurance,0.6012215119528499,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6313170504947208,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.585230962318237,
AH2018_LFQ_M_2_X,0.6165259941700012,
AH2018_LFQ_IT_4_N,0.5891963249492751,
CK2022_15 200-1,0.606692690232005,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5664326349195375,
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.57709842945275,
CK2022_2 200-1,0.6073605185520974,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6287679645551536,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.44835884827270445
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6016463401058613,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.619472821908706,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.6281038305628176,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.6209585370730528,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.6331063323643498,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.5911993404551573,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5731430866628251,
AH2018_SILAC_M_2_X,0.569933946185307,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.628045786775705,
PG2020_Intensity 6h_C,0.5472310360355843,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.5908466304288111,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6171150189898238,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5784564363571418,
CK2022_15 16-1,0.5778092132159759,
CK2022_3 16-1,0.5929613213045777,
LY2019_P4-,0.5856632811252471,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.6010987824892677,
GF2025_P8_Adh,0.610176047127639,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.5935115698635653,
GF2025_P5_Sph,0.598968863972533,
CK2022_10 16-1,0.580725799476156,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.6075377199633658,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5938376232318656,
EJN2021_2_Ex_Basal,,0.44531719158069716
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5387234031997277,
CF2017_EOC 2,,0.4397934846710152
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5939563478922035,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.607383169729883,
RB2022_7_PreSprint,0.6050926970978193,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.6228966739407572,
CK2022_6 16-1,0.5740446484528093,
ZX2022_CB treated Replicate 1,0.5939852710189515,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.4150136016031364
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,0.6010993630051359,
RB2022_1_PreStrength,0.6102829364254782,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5800456185572113,
AR2021_L41 1 μM,0.5470754054417482,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5750394763747961,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.6056844941476615,
ZX2022_Control Replicate 3,0.5946937657098824,
KS2014_Intensity C4,0.626658913469746,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,0.6082374435758705,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5766189411780644,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6185046206192099,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.6157238267681346,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5939373131036294,
AH2018_SILAC_IT_3_C,0.590404479492906,
WZ2023_Pu_025_10min,0.6261805335770049,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.4465096540921669
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.628381236161002,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5708942443864519,
KS2014_Intensity C6,0.6294908544357887,0.41902332334115855
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5864976187164265,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.598214368322559,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5834057853337477,
AH2018_SILAC_IT_2_C,0.5933526136207917,
CK2022_5 40-1,0.5877808515223241,
AH2018_LFQ_3_X,,
UK2020_UA_3,0.607272921307773,
LY2019_P7-,0.6151113934133117,
GF2025_P5_Adh,0.6219620765697149,
RB2022_1_PostStrength,0.603482766674337,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5804853637663033,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5823610441528159,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5932613345381291,
PG2020_Intensity CT_B,0.5802987591989339,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6166426174526283,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.6136882879212187,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6160249480680762,
YA2020_Reporter_intensity_Cancer_No.4,0.6217568097663735,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5793881078845763,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,0.5919366310465818,
CK2022_14 16-1,0.5729971186249557,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.6068095956377018,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.6317592748929834,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5915254487445833,
AH2018_TMTMS2_1_X,0.5833020869330512,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.45120608273991564
HS2024_6_I_N2,0.6333627357108671,
HH2022_Reporter intensity 4,,0.46561490496909785
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.640699995311283,
AH2018_SILAC_1_X,0.5966464629946516,
PG2020_Intensity 10h_B,0.5740313861639179,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5610704774707701,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5692842727708536,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.6293156708739992,
HS2024_5_I_N2,0.6190054402716558,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5768379939225559,
AS2011_Ratio H/L Normalized RNAi_2_1,,
